Pharmacogenomics and Personalized Medicine in Neuropsychiatry

Francis J. McMahon, Thomas R. Insel

Research output: Contribution to journalShort surveypeer-review


Despite the need for more effective treatments for psychiatric disorders, development of new medications has stalled. Here we discuss the promise of personalized medicine in developing more efficacious and individualized pharmacotherapies that take into account genetic variation and target groups of patients who share biology, not just symptoms.

Original languageEnglish (US)
Pages (from-to)773-776
Number of pages4
Issue number5
StatePublished - Jun 7 2012
Externally publishedYes

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Pharmacogenomics and Personalized Medicine in Neuropsychiatry'. Together they form a unique fingerprint.

Cite this